SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting-Reference-Cited by-同舟云学术

SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting

Published:2021-10 Issue:10 Volume:174 Page:1404-1408
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Butt Adeel A.¹^ORCID,Omer Saad B.²,Yan Peng³,Shaikh Obaid S.⁴,Mayr Florian B.⁵^ORCID

Affiliation:

1. VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, Weill Cornell Medical College, New York, New York, and Weill Cornell Medical College and Hamad Medical Corporation, Doha, Qatar (A.A.B.)

2. Yale School of Medicine, New Haven, Connecticut (S.B.O.)

3. VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania (P.Y.)

4. VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (O.S.S.)

5. VA Pittsburgh Healthcare System, University of Pittsburgh School of Medicine, and University of Pittsburgh, Pittsburgh, Pennsylvania (F.B.M.).

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world comparative effectiveness of a third dose of mRNA-1273 versus BNT162b2 among adults aged ≥ 65 years in the United States;Vaccine;2024-11

2. COVID-19 Breakthrough Infections Among People With HIV: A Statewide Cohort Analysis;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-10-01

3. Nirmatrelvir/ritonavir or Molnupiravir for treatment of non-hospitalized patients with COVID-19 at risk of disease progression;PLOS ONE;2024-06-06

4. The Study of the COVID-19 Virus: A Review;The Open COVID Journal;2024-06-06

5. The impact of COVID‐19 on the clinical course and outcome of patients with cirrhosis: An observational study;Health Science Reports;2024-06